Home > Journals > Minerva Pediatrica > Past Issues > Minerva Pediatrica 2017 June;69(3) > Minerva Pediatrica 2017 June;69(3):219-24

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

REVIEW   

Minerva Pediatrica 2017 June;69(3):219-24

DOI: 10.23736/S0026-4946.16.04365-6

Copyright © 2015 EDIZIONI MINERVA MEDICA

language: English

Cardiac insufficiency in infants

Chunli LI, Xinjiang AN, Ling NIU, Haining ZHANG, Zhenzhou WANG, Mingyu FU

Department of Cardiology, Xuzhou Children’s Hospital, Xuzhou, China


PDF


Cardiac failures in young children have shown an enormous trudge in recent past. The reason being medical community has laid more stress on cardiac insufficiency management on adult patients and has conducted a large amount of research on the management of heart failure in adults, which has given rise to significant changes in management in the last decade. However, there are far fewer studies in children and those which do exist are often small, retrospective and use a diverse range of measures to assess efficacy. Current research is being focused worldwide to deal with this life threatening problem of young patients. The present review shall enlighten the above focus of the research and will discuss latest developments in therapeutic advances like paediatric use of ace inhibitors, beta blockers in young patients for the efficient management of cardiac insufficiency.


KEY WORDS: Heart failure - Cardiac insufficiency - Angiotensin-converting enzyme inhibitors

top of page